Capstone Powerpoint PresentationCapstone Powerpoint Presentation
Loading in … 5
Like this presentation? Why not share!
- 1. The Effect of an Educational Program for Nursing Students on HPV Disease and Vaccine
Colleen R. Barrett, MSN, CRNP, DNP (c)
Mary Cothran, PhD, CRNP, FNP-BC
To determine the effect of an educational program about human papillomavirus (HPV) on the knowledge base of baccalaureate nursing students
- 3.Implications for Study
Limited research has shown a knowledge deficit about HPV among nursing students
Educational programs on HPV for this group may translate to improved personal and public health
- 4.Background and Significance
Most common STI in the US (1,2)
Infects 6.2 million US residents annually (1)
- 5.Background and Significance
Over 100 strains; at least 40 known to be oncogenic (3).
Types 6 and 11-low risk. Cause majority of genital warts (condyloma) (4).
Types 16 and 18 most oncogenic. Together cause over 80% of cervical cancers (4).
- 6.Cervical Cancer
In the US in 2005 (7)
11,999 newly diagnosed
3,924 died of the disease
- 7.Cervical Cancer
HPV causes over 500,000 cases of genital cancers annually
370,000 of those are known cervical cancers
270,000 of those will lead to death
- 8.HPV prevention
Primary prevention of the human papillomavirus is now possible.
- 9.HPV PREVENTION
June 2006: prophylactic, quadrivalent HPV 6/11/16/18 VLP vaccine (Gardasil) was licensed for use
Indicated for males and females ages 9-26
Has been shown to prevent up to 70% of cervical cancers caused by HPV 16/18 (14).
- 10.Knowledge Deficit
Numerous surveys on college campuses in US and Canada:
Low level of HPV knowledge among college students and nursing students
- 11.Knowledge Deficit
Ingledue, et al.
Denny-Smith, et al.
Both studies revealed poor knowledge, low perception and high risk sexual behaviors
- 12.Knowledge Deficit
Data support the need to educate adolescents and women about HPV
Studies reveal women desire more information about HPV (24)
- 13.HPV Education
Few studies on effect of HPV-focused educational programs
Lambert (25) evaluated the effectiveness of a brief HPV focused educational program
Physician Assistant and Psychology students
Data revealed statistically significant improvement in HPV knowledge scores after the program
- 14.STD and Pregnancy Prevention Programs
Have been shown in literature to be successful
Anderko and Uscian (22)
Studied decreasing risky sexual behavior
Research review revealed success with educational
programs on HIV prevention
- 15.Study Design
Convenience sample of full time senior level undergraduate nursing students (n=18)
Demographic data analyzed using frequencies and averages
Mean age of students was 22.53 years (SD 1.13) –after removal of 3 outliers (ages 33, 37, 42)
Participation was voluntary
Completion of study materials considered implied consent
No incentives offered for participation
Study approved by IRB at RMU and Human Subject’s Review Board at host university
The Awareness of HPV and Cervical Cancer Questionnaire (23)
40 item multiple choice questionnaire
Developed to assess knowledge, perceptions, and preventive behaviors regarding HPV and cervical cancer
Permission to use granted by author, Ingledue (23)
Stability reliability established by test-retest procedures
Test-retest coefficients of 0.90 reported for knowledge; 0.95 for perceptions and 0.90 for behaviors
No data reported for internal consistency
Content validity established via consensual validity using a panel of health experts
Instrument was approved by a Human Subject’s committee
For present study, only the knowledge items of the instrument were used
Multiple choice questions
One correct answer
Correct answers assigned one point
Score range of 0 to 15
- 22.Data Collection
Demographic questionnaire with cover letter describing study
Questionnaires numbered by author
Pre-test/post test-numbered by participants
All placed in privacy envelopes upon completion.
- 23.Educational Intervention
Increase general knowledge of HPV disease and its sequelae
Risk factors for HPV and cervical cancer
Symptoms of HPV infection
Means to prevent HPV and cervical cancer
Means of detecting HPV and cervical cancer
- 24.Educational Intervention
HPV incidence, prevalence and pathogenesis
HPV risk factors and sequelae
Various stages of cervical dysplasia and cervical cancer
Cervical cancer statistics
Quadrivalent HPV vaccine
- 25.Educational Intervention
Concluded with open question and answer period
- 26.Data Analysis
Data entered into Access Excel
Analysis performed using SPSS 17.0
Mean of pre-test: 10.83 (SD 1.043)
Mean of post-test: 13.78 (SD 1.166)
Mean pre-test score: 72%
Mean post-test score: 91%
Undergraduate nursing students
Will be able to disseminate accurate information about HPV disease and vaccine to patients
May be of the age group recommended to receive the vaccine themselves
Improved knowledge in this group may contribute to public health both directly and indirectly
Small sample size
Homogeneity of sample
Vaccine knowledge not assessed
38.9% of students reported some previous education on HPV disease
Entire tool not utilized
- 31.Future Research
Should include larger sample size
Nursing students in various pre-licensure programs
More heterogeneous sample
Assess knowledge retention over time
Vaccine knowledge (instrument development)
Vaccination status pre- and post-program
Include practicing nurses and their practice habits as they pertain to patient education
- 32.Implications for Study
HPV incidence and subsequent cervical disease burden may be reduced through education of nurses
Nurses can have positive effect public health as they disseminate accurate information
1. Fontenot HB, Collins Fantasia H, Allen JD. HPV in adolescents: Making the wake up call. Adv Nurse Pract. 2007;15(10): 73-76.
2. Denny-Smith T, Bairan A, Page M. C. A survey of female nursing students’ knowledge, health beliefs, perceptions of risk, and risk behaviors regarding human papillomavirus and cervical cancer. J AmAcad Nurse Pract. 2006;18:62-69.
3. O’Brien J. 11th annual conference on vaccine research. Expert RevVaccines. 2008;7(6):721-723.
4. Bosch, FX, & de Sanjose, S. (2003). Chapter 1: Human papillomavirus and cervical cancer burden and assessment of causality. J Natl CancerInst Monogr. 2003;31;3-13
5. Walboomers JMM, Jacobs M, Manos N, Bosch F, Kummer A, Shah K. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
6. Oaknin A, Pilar-Barretina M. Human papillomavirus vaccine and cervical cancer prevention. Clin and Transl Oncology. 2008;10:804-811.
7. Cervical cancer statistics. Centers for Disease Control Website. http://www.cdc.gov/cancer/cervical/statistics/index.htm. Updated July 20, 2009. Accessed September 3, 2009.
8. Buttin B, Herzog T, Mutch D. Abnormal cytology and human papillomavirus. In: Curtis M, Overholt S, Hopkins M. Glass’ Office Gynecology. 6th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2006:80-106
9. Block S, Nolan T, Sattler C, Barr E, Giacoletti KED, Marchant CD, et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) l1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics. 2006;118(5);2135-2145.
10. Future I Study Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N England J Med. 2007;356(19):1928-1943.
11. Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of mortality from 25 cancers in 1990. Int J Cancer. 1999;80:827-841.
15. Cancer Prevention & Early Detection Facts & Figures. American Cancer Society Website
http://www.cancer.org/downloads/STT/CPED_2008.pdf. Reported as of November 30, 2007. Accessed September 3, 2009.
16. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810-819.
17. Adams M, Jasani B, Fiander, A. Human papillomavirus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine. 2007;25:3007-3013.
18. Future II study group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915-1927.
19. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Psychosocial aspects of vaccine acceptability. Vaccine. 2006;24S3, S3/201-S3/209.
20. Ramirez J, Ramos D, Clayton L, Kanowitz S, Moscicki. Genital human papillomavirus infections: Knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health. 1997;6:113-121.
21. Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res. 2002;17(6):706-714.
22. Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: implications for health education research. J Community Health. 2000;25:67-78.
23. Yacobi E, Tennant C, Ferrante J, Naazneen P, Roetzheim R. University students' knowledge and awareness of HPV. Prev Med. 1999; 28:535-541.
24. Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health. 2005;37:19-23.
25. Anderko L, Uscian M. Academic-community partnerships as a strategy for positive change in the sexual behavior of rural college-age students. Nurs Clin North Am. 2002;37:341-349.
26. Ingledue K, Cottrell R, Bernard A. College women’s knowledge, perceptions, and preventive behaviors regarding human papillomavirus infection and cervical cancer. Am J of Health Stud. 2004;19(1):28-34.
27. Holcomb B, Bailey J, Crawford K, Ruffin M. Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Practice. 2004;17(1):26-31.
28. Lambert E. College students’ knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract. 2001;14(3):178-183.
29. Kirby D. Emerging answers: research findings on programs to reduceteen pregnancy (summary). Washington, DC: National Campaign to Prevent Teen Pregnancy. 2001.
Category: Capstone project